STAT Plus: Safety concerns regarding Novartis’ new eye drug boost Regeneron stock
VANESSA BUMBEERS/UNSPLASH
The American Society of Retina Specialists said some patients were experiencing both a known side effect and a new one after being treated with Beovu.


No hay comentarios:
Publicar un comentario